Global Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Influenza Vaccine market size was valued at USD 8056.5 million in 2022 and is forecast to a readjusted size of USD 11570 million by 2029 with a CAGR of 5.3% during review period.

Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

The Global Info Research report includes an overview of the development of the Influenza Vaccine industry chain, the market status of 6 Months to 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), > 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Influenza Vaccine.

Regionally, the report analyzes the Influenza Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Influenza Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Influenza Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Influenza Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Units), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Influenza Vaccine market.

Regional Analysis: The report involves examining the Influenza Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Influenza Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Influenza Vaccine:
Company Analysis: Report covers individual Influenza Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Influenza Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months to 3 Years, > 3 Years).

Technology Analysis: Report covers specific technologies relevant to Influenza Vaccine. It assesses the current state, advancements, and potential future developments in Influenza Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Influenza Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine

Market segment by Application
    6 Months to 3 Years
    > 3 Years

Major players covered
    Sanofi
    CSL
    GSK
    Viatris
    AstraZeneca
    Hualan Bio
    Changchun Institute of Biological
    Sinovac
    BCHT
    Jiangsu GDK
    KM Biologics

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza Vaccine, with price, sales, revenue and global market share of Influenza Vaccine from 2018 to 2023.
Chapter 3, the Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza Vaccine.
Chapter 14 and 15, to describe Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Influenza Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Influenza Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Trivalent Influenza Vaccine
        1.3.3 Quadrivalent Influenza Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Influenza Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 6 Months to 3 Years
        1.4.3 > 3 Years
    1.5 Global Influenza Vaccine Market Size & Forecast
        1.5.1 Global Influenza Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Influenza Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Influenza Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Influenza Vaccine Product and Services
        2.1.4 Sanofi Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Sanofi Recent Developments/Updates
    2.2 CSL
        2.2.1 CSL Details
        2.2.2 CSL Major Business
        2.2.3 CSL Influenza Vaccine Product and Services
        2.2.4 CSL Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 CSL Recent Developments/Updates
    2.3 GSK
        2.3.1 GSK Details
        2.3.2 GSK Major Business
        2.3.3 GSK Influenza Vaccine Product and Services
        2.3.4 GSK Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 GSK Recent Developments/Updates
    2.4 Viatris
        2.4.1 Viatris Details
        2.4.2 Viatris Major Business
        2.4.3 Viatris Influenza Vaccine Product and Services
        2.4.4 Viatris Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Viatris Recent Developments/Updates
    2.5 AstraZeneca
        2.5.1 AstraZeneca Details
        2.5.2 AstraZeneca Major Business
        2.5.3 AstraZeneca Influenza Vaccine Product and Services
        2.5.4 AstraZeneca Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 AstraZeneca Recent Developments/Updates
    2.6 Hualan Bio
        2.6.1 Hualan Bio Details
        2.6.2 Hualan Bio Major Business
        2.6.3 Hualan Bio Influenza Vaccine Product and Services
        2.6.4 Hualan Bio Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Hualan Bio Recent Developments/Updates
    2.7 Changchun Institute of Biological
        2.7.1 Changchun Institute of Biological Details
        2.7.2 Changchun Institute of Biological Major Business
        2.7.3 Changchun Institute of Biological Influenza Vaccine Product and Services
        2.7.4 Changchun Institute of Biological Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Changchun Institute of Biological Recent Developments/Updates
    2.8 Sinovac
        2.8.1 Sinovac Details
        2.8.2 Sinovac Major Business
        2.8.3 Sinovac Influenza Vaccine Product and Services
        2.8.4 Sinovac Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Sinovac Recent Developments/Updates
    2.9 BCHT
        2.9.1 BCHT Details
        2.9.2 BCHT Major Business
        2.9.3 BCHT Influenza Vaccine Product and Services
        2.9.4 BCHT Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 BCHT Recent Developments/Updates
    2.10 Jiangsu GDK
        2.10.1 Jiangsu GDK Details
        2.10.2 Jiangsu GDK Major Business
        2.10.3 Jiangsu GDK Influenza Vaccine Product and Services
        2.10.4 Jiangsu GDK Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Jiangsu GDK Recent Developments/Updates
    2.11 KM Biologics
        2.11.1 KM Biologics Details
        2.11.2 KM Biologics Major Business
        2.11.3 KM Biologics Influenza Vaccine Product and Services
        2.11.4 KM Biologics Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 KM Biologics Recent Developments/Updates

3 Competitive Environment: Influenza Vaccine by Manufacturer
    3.1 Global Influenza Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Influenza Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Influenza Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Influenza Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Influenza Vaccine Manufacturer Market Share in 2022
    3.5 Influenza Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Influenza Vaccine Market: Region Footprint
        3.5.2 Influenza Vaccine Market: Company Product Type Footprint
        3.5.3 Influenza Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Influenza Vaccine Market Size by Region
        4.1.1 Global Influenza Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Influenza Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Influenza Vaccine Average Price by Region (2018-2029)
    4.2 North America Influenza Vaccine Consumption Value (2018-2029)
    4.3 Europe Influenza Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Influenza Vaccine Consumption Value (2018-2029)
    4.5 South America Influenza Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Influenza Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Influenza Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Influenza Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Influenza Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Influenza Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Influenza Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Influenza Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Influenza Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Influenza Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Influenza Vaccine Market Size by Country
        7.3.1 North America Influenza Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Influenza Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Influenza Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Influenza Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Influenza Vaccine Market Size by Country
        8.3.1 Europe Influenza Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Influenza Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Influenza Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Influenza Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Influenza Vaccine Market Size by Region
        9.3.1 Asia-Pacific Influenza Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Influenza Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Influenza Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Influenza Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Influenza Vaccine Market Size by Country
        10.3.1 South America Influenza Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Influenza Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Influenza Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Influenza Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Influenza Vaccine Market Size by Country
        11.3.1 Middle East & Africa Influenza Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Influenza Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Influenza Vaccine Market Drivers
    12.2 Influenza Vaccine Market Restraints
    12.3 Influenza Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Influenza Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Influenza Vaccine
    13.3 Influenza Vaccine Production Process
    13.4 Influenza Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Influenza Vaccine Typical Distributors
    14.3 Influenza Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Influenza Vaccine Product and Services
    Table 6. Sanofi Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Sanofi Recent Developments/Updates
    Table 8. CSL Basic Information, Manufacturing Base and Competitors
    Table 9. CSL Major Business
    Table 10. CSL Influenza Vaccine Product and Services
    Table 11. CSL Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. CSL Recent Developments/Updates
    Table 13. GSK Basic Information, Manufacturing Base and Competitors
    Table 14. GSK Major Business
    Table 15. GSK Influenza Vaccine Product and Services
    Table 16. GSK Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. GSK Recent Developments/Updates
    Table 18. Viatris Basic Information, Manufacturing Base and Competitors
    Table 19. Viatris Major Business
    Table 20. Viatris Influenza Vaccine Product and Services
    Table 21. Viatris Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Viatris Recent Developments/Updates
    Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 24. AstraZeneca Major Business
    Table 25. AstraZeneca Influenza Vaccine Product and Services
    Table 26. AstraZeneca Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. AstraZeneca Recent Developments/Updates
    Table 28. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 29. Hualan Bio Major Business
    Table 30. Hualan Bio Influenza Vaccine Product and Services
    Table 31. Hualan Bio Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Hualan Bio Recent Developments/Updates
    Table 33. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
    Table 34. Changchun Institute of Biological Major Business
    Table 35. Changchun Institute of Biological Influenza Vaccine Product and Services
    Table 36. Changchun Institute of Biological Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Changchun Institute of Biological Recent Developments/Updates
    Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
    Table 39. Sinovac Major Business
    Table 40. Sinovac Influenza Vaccine Product and Services
    Table 41. Sinovac Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Sinovac Recent Developments/Updates
    Table 43. BCHT Basic Information, Manufacturing Base and Competitors
    Table 44. BCHT Major Business
    Table 45. BCHT Influenza Vaccine Product and Services
    Table 46. BCHT Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. BCHT Recent Developments/Updates
    Table 48. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
    Table 49. Jiangsu GDK Major Business
    Table 50. Jiangsu GDK Influenza Vaccine Product and Services
    Table 51. Jiangsu GDK Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Jiangsu GDK Recent Developments/Updates
    Table 53. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 54. KM Biologics Major Business
    Table 55. KM Biologics Influenza Vaccine Product and Services
    Table 56. KM Biologics Influenza Vaccine Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. KM Biologics Recent Developments/Updates
    Table 58. Global Influenza Vaccine Sales Quantity by Manufacturer (2018-2023) & (M Units)
    Table 59. Global Influenza Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 60. Global Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 61. Market Position of Manufacturers in Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 62. Head Office and Influenza Vaccine Production Site of Key Manufacturer
    Table 63. Influenza Vaccine Market: Company Product Type Footprint
    Table 64. Influenza Vaccine Market: Company Product Application Footprint
    Table 65. Influenza Vaccine New Market Entrants and Barriers to Market Entry
    Table 66. Influenza Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 67. Global Influenza Vaccine Sales Quantity by Region (2018-2023) & (M Units)
    Table 68. Global Influenza Vaccine Sales Quantity by Region (2024-2029) & (M Units)
    Table 69. Global Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 70. Global Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 71. Global Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 72. Global Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 73. Global Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
    Table 74. Global Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
    Table 75. Global Influenza Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Global Influenza Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Global Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 78. Global Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 79. Global Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
    Table 80. Global Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
    Table 81. Global Influenza Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 82. Global Influenza Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 83. Global Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 84. Global Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 85. North America Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
    Table 86. North America Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
    Table 87. North America Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
    Table 88. North America Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
    Table 89. North America Influenza Vaccine Sales Quantity by Country (2018-2023) & (M Units)
    Table 90. North America Influenza Vaccine Sales Quantity by Country (2024-2029) & (M Units)
    Table 91. North America Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. North America Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Europe Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
    Table 94. Europe Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
    Table 95. Europe Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
    Table 96. Europe Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
    Table 97. Europe Influenza Vaccine Sales Quantity by Country (2018-2023) & (M Units)
    Table 98. Europe Influenza Vaccine Sales Quantity by Country (2024-2029) & (M Units)
    Table 99. Europe Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 100. Europe Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 101. Asia-Pacific Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
    Table 102. Asia-Pacific Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
    Table 103. Asia-Pacific Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
    Table 104. Asia-Pacific Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
    Table 105. Asia-Pacific Influenza Vaccine Sales Quantity by Region (2018-2023) & (M Units)
    Table 106. Asia-Pacific Influenza Vaccine Sales Quantity by Region (2024-2029) & (M Units)
    Table 107. Asia-Pacific Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 108. Asia-Pacific Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 109. South America Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
    Table 110. South America Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
    Table 111. South America Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
    Table 112. South America Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
    Table 113. South America Influenza Vaccine Sales Quantity by Country (2018-2023) & (M Units)
    Table 114. South America Influenza Vaccine Sales Quantity by Country (2024-2029) & (M Units)
    Table 115. South America Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 116. South America Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 117. Middle East & Africa Influenza Vaccine Sales Quantity by Type (2018-2023) & (M Units)
    Table 118. Middle East & Africa Influenza Vaccine Sales Quantity by Type (2024-2029) & (M Units)
    Table 119. Middle East & Africa Influenza Vaccine Sales Quantity by Application (2018-2023) & (M Units)
    Table 120. Middle East & Africa Influenza Vaccine Sales Quantity by Application (2024-2029) & (M Units)
    Table 121. Middle East & Africa Influenza Vaccine Sales Quantity by Region (2018-2023) & (M Units)
    Table 122. Middle East & Africa Influenza Vaccine Sales Quantity by Region (2024-2029) & (M Units)
    Table 123. Middle East & Africa Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 124. Middle East & Africa Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 125. Influenza Vaccine Raw Material
    Table 126. Key Manufacturers of Influenza Vaccine Raw Materials
    Table 127. Influenza Vaccine Typical Distributors
    Table 128. Influenza Vaccine Typical Customers
List of Figures
    Figure 1. Influenza Vaccine Picture
    Figure 2. Global Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Influenza Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Trivalent Influenza Vaccine Examples
    Figure 5. Quadrivalent Influenza Vaccine Examples
    Figure 6. Global Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Influenza Vaccine Consumption Value Market Share by Application in 2022
    Figure 8. 6 Months to 3 Years Examples
    Figure 9. > 3 Years Examples
    Figure 10. Global Influenza Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Influenza Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Influenza Vaccine Sales Quantity (2018-2029) & (M Units)
    Figure 13. Global Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 14. Global Influenza Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 15. Global Influenza Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 16. Producer Shipments of Influenza Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 17. Top 3 Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 18. Top 6 Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Global Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 20. Global Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 21. North America Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 22. Europe Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 23. Asia-Pacific Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. South America Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. Middle East & Africa Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Global Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 27. Global Influenza Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 28. Global Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 29. Global Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 30. Global Influenza Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 31. Global Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 32. North America Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 33. North America Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 34. North America Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 35. North America Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 37. Canada Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Mexico Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Europe Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 40. Europe Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 41. Europe Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 42. Europe Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 43. Germany Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 44. France Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. United Kingdom Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. Russia Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Italy Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Asia-Pacific Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 49. Asia-Pacific Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 50. Asia-Pacific Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 51. Asia-Pacific Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 52. China Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 53. Japan Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Korea Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. India Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Southeast Asia Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Australia Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. South America Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 59. South America Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 60. South America Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 61. South America Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 62. Brazil Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 63. Argentina Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Middle East & Africa Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 65. Middle East & Africa Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 66. Middle East & Africa Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 67. Middle East & Africa Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 68. Turkey Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 69. Egypt Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Saudi Arabia Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. South Africa Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Influenza Vaccine Market Drivers
    Figure 73. Influenza Vaccine Market Restraints
    Figure 74. Influenza Vaccine Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Influenza Vaccine in 2022
    Figure 77. Manufacturing Process Analysis of Influenza Vaccine
    Figure 78. Influenza Vaccine Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Companies Mentioned

Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics